Synabs SA
5.1 FTEThe score of Synabs shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +49 % Total assets -4 % Headcount (avg FTE) -31 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Synabs's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jun 2026
- Year ended 31 Dec 2024filed on 04 Apr 2025
- Year ended 31 Dec 2023filed on 17 May 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 18 Jul 2022
Synabs's financial analysis
- Solvency67.4%sector median: 43.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Synabs
Synabs's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0637.716.206
- VAT number
- BE0637716206
- Peppol
- Registered · 0208:0637716206 · as of 08 Nov 2026
- Legal form
- SA
- Incorporated
- 14 Sep 2015
- Registered office
- 6041 Charleroi
- Size
- Micro · 5.1 FTE
- Latest accounts
- 2025 · filed on 22 Jun 2026
- Activity
- Manufacture of other chemical products n.e.c. (NACE 20590)
Synabs (SA) has been based in Charleroi since 2015, active in: manufacture of other chemical products n.e.c.. For 2025, it reports a net profit of 83,206 € and equity of 746,999 €; its revenue is not published. With 5.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 67.4%, above the median of its sector (43.8%).
Companies similar to Synabs
Companies in the same business, of comparable size and area, outside its group.
- Asterion Research & Development Research and experimental development on natural sciences and engineering Ghent · balance sheet €2.31m
- Dokter Bart Gordts Research and experimental development on natural sciences and engineering Bruges · balance sheet €1.19m
- Protea Biopharma NV Research and experimental development on natural sciences and engineering Asse · balance sheet €1.30m
- Abaxys Therapeutics Research and experimental development on natural sciences and engineering Villers-la-Ville · balance sheet €1.31m
- Global Mobile Lab Research and experimental development on natural sciences and engineering Saint-Hubert · balance sheet €1.26m
- Europe Inland Logistics Solar 21 Research and experimental development on natural sciences and engineering Herentals · balance sheet €1.33m
- Frid Mind Technologies Research and experimental development on natural sciences and engineering Charleroi · balance sheet €1.15m
- Taag Venture Capital Europe Research and experimental development on natural sciences and engineering Antwerp · balance sheet 845,167 €
Frequently asked questions about Synabs
What is the revenue of Synabs?
Synabs files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Synabs?
In Belgium, the VAT number is the company number prefixed with BE: BE0637716206 for Synabs, if the company is VAT-registered. Its company number (CBE) is 0637.716.206.
Where is the registered office of Synabs?
According to the CBE register, the registered office of Synabs is in 6041 Charleroi.
What is the equity of Synabs?
At the close of the 2025 financial year, the equity of Synabs amounts to 746,999 €, a solvency of 67.4% of total assets.
How many people work at Synabs?
5.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Synabs?
The register lists 3 active mandates at Synabs. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Synabs
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →